Alcon, the global leader in eye care dedicated to helping people see brilliantly, today proudly announces AcrySof IQ Vivity and Clareon Vivity extended depth of focus (EDOF) intraocular lens (IOL) has surpassed more than one million implants worldwide. Vivity is the most implanted EDOF IOL globally.

Alcon is the global leader in IOLs—every four seconds an eye is implanted with an Alcon IOL—and continues to innovate in this space to address patients’ unmet needs.

“We are proud to celebrate the one million Vivity eyes empowering cataract patients to see the world with high quality vision from distance to functional near—day and night,” said Amar Vyas, Country Head for Alcon India. “This milestone embodies our commitment to addressing the diverse vision needs of today's patients—who desire less dependence on glasses post-surgery and with monofocal visual disturbance profile —with a game-changing option that expands the patient candidacy pool.”

Vivity uses Alcon’s proprietary wavefront-shaping X-WAVETM technology, an advanced optical principal that simultaneously stretches and shifts light without splitting it—balancing quality of vision and maximizing range of vision.